Cells experiencing DNA damage undergo a complex response entailing cell-cycle arrest, DNA repair and apoptosis, the relative importance of the three being modulated by the extent of the lesion. The observation that Abl interacts in the nucleus with several proteins involved in different aspects of DNA repair has led to the hypothesis that this kinase is part of the damage-sensing mechanism. However, the mechanistic details underlying the role of Abl in DNA repair remain unclear. Here, I will review the evidence supporting our current understanding of Abl activation following DNA insults, while focusing on the relevance of these mechanisms in protecting DNAinjured germ cells. Early studies have shown that Abl transcripts are highly expressed in the germ line. Abldeficient mice exhibit multiple abnormalities, increased perinatal mortality and reduced fertility. Recent findings have implicated Abl in a cisplatin-induced signaling pathway eliciting death of immature oocytes. A p53-related protein, TAp63, is an important immediate downstream effector of this pathway. Of note, pharmacological inhibition of Abl protects the ovarian reserve from the toxic effects of cisplatin. This suggests that the extent of Abl catalytic outputs may shift the balance between survival (likely through DNA repair) and activation of a death response. Taken together, these observations are consistent with the evolutionary conserved relationship between DNA damage and activation of the p53 family of transcription factors, while shedding light on the key role of Abl in dictating the fate of germ cells upon genotoxic insults.
Introduction
DNA lesions, and in particular double-strand breaks (DSBs), are difficult to repair and extremely toxic (Khanna and Jackson, 2001; Dery and Masson, 2007;  Jackson and Bartek, 2009 ). DSBs can arise as a result of exogenous or endogenous insults such as genotoxic stress, or replication fork defects (Ward, 1988; Michel et al., 1997) . DSBs are also formed during meiosis to promote homologous recombination (Sun et al., 1989) . A concerted action of three classes of proteins coordinates the response to DNA damage response in the cell. Sensors sense the presence of DNA lesions, signal transducers generate and amplify the DNA damage signal, effectors induce cell-cycle delay and, in some cases, programmed cell death or senescence. The cellcycle delay allows time for DNA repair (Weinert and Hartwell, 1988) . However, when excessive genome damage occurs, cells undergo either apoptosis or senescence, thus preventing the accumulation of potentially tumorigenic mutations (Bartkova et al., 2005; Gorgoulis et al., 2005) . Proper activation and inactivation of DNA damage repair and of DNA signaling mechanisms are finely regulated by post-translational modifications. Although several types of modifications, such as phosphorylation, acetylation, methylation, ubiquitination and sumoylation, can occur, they do rely extensively on inducible, phosphorylation-dependent, protein-protein interactions of the DNA damage response components. The key events of DNA damage signaling are recruitment and activation of Ataxia telangiectasia mutated (ATM), DNA-PK and ATR kinases. ATM (DNA-PK, ATR) downstream targets are the histone H2A variant H2AX, the DNA damage checkpoint proteins and p53 (Kastan and Bartek, 2004; Bartek and Lukas, 2007; Riley et al., 2008; Panier and Durocher, 2009 ). Abl forms a complex with several components both of the DNA repair and of DNA signaling mechanisms even in the absence of damage. However, Abl activity is turned on, in an ATMdependent manner (or in a DNA-PK-dependent manner), only after ionizing radiation (IR) Shafman et al., 1997; Kharbanda et al., 1997b; Collis et al., 2005) .
Germ cells are more sensitive to DNA insults compared with somatic cells; oocytes from primordial follicles are almost completely destroyed even at low doses of radiation (Morita et al., 2000) . Accordingly, ovarian failure and infertility are often off-target consequences of anti-tumoral therapies. Recent evidence indicates that Abl promotes death of perinatal oocytes following cisplatin treatment. Phosphorylation of TAp63 by Abl is seen as a key event in such a response; in line with this, pharmacological targeting of Abl abolishes the lethal effect of cisplatin on the ovarian reserve (Gonfloni et al., 2009 ). These observations seem to indicate a new approach for preserving fertility in cancer survivors (Woodruff, 2009 ). The present review summarizes current knowledge about the nuclear processes involving Abl and also discusses possible implications as regards germ-cell physiology.
Abl
Abl is a non-receptor tyrosine kinase implicated in many diverse cellular processes, including those originating from growth-factor stimulation, cell adhesion, oxidative stress and DNA damage (Pendergast, 2002; Zhu and Wang, 2004; Wang, 2004; Sirvent et al., 2008; Gu et al., 2009) . Abl ablation in mice results in pleiotropic defects, including neonatal lethality, reduced fertility, lymphopenia and osteoporosis (Schwartzberg et al., 1991; Tybulewicz et al., 1991; Li et al., 2000) .
Abl localizes into both the nucleus and the cytoplasm (Taagepera et al., 1998; Wang, 2000) . Nucleo-cytoplasmic shuttling and the catalytic activation of Abl are apparently modulated by post-translational modifications (Yoshida, 2008) . Some early reports initially outlined a negative role of Abl in controlling cell proliferation (Sawyers et al., 1994; Wen et al., 1996) . However, Abl appears to have antagonistic functions depending on its subcellular localization; indeed, targeting of the cytoplasmic oncogenic Abl variant to the nucleus leads to apoptosis (Vigneri and Wang, 2001) . A role of Abl in cytoplasmic signaling has emerged only recently and has been reviewed in detail by Sirvent et al., albeit not further discussed in this review.
Structure, regulation and nuclear targets of Abl
The Abl family includes two genes Abl (ABL-1) and Arg (Abl-related gene, ABL-2), each gene encoding two splicing isoforms (1a and 1b), differing at the N-terminus for the presence of a myristoylation site (present in 1b). Structural and biochemical analyses of Abl have provided solid evidence in favor of an autoinhibition mechanism (Hantschel and Superti-Furga, 2004) . Intramolecular interactions of the autoinhibited structure closely match those in the inactive conformation of Src Williams et al., 1997; Xu et al., 1997) . However, the threedimensional structure of Abl shows that the kinase is locked in an inactive state by the insertion of an N-terminal myristoyl group into a deep hydrophobic pocket at the base of the kinase domain Nagar et al., 2003) . This results in an inactive open conformation selectively targeted by the smallmolecule inhibitor imatinib STI571 (Imatinib, methanesulfonate Salt, LC Laboratories, Woburn, MA, USA) (Schindler et al., 2000; Nagar et al., 2003; Nagar, 2007) .
Abl activation is coupled with substrate recognition. As mentioned before, Abl binds to and phosphorylates several proteins involved in DNA repair. Interestingly, all these protein partners contain a PXXP motif that binds the Abl SH3 domain. Some of them are involved in homologous recombination repair of DSBs like RAD51 and RAD52 (Chen et al., 1999a; Kitao and Yuan, 2002) , and in the mismatch repair (MMR) system (Nehme et al., 1997; Gong et al., 1999; Yi et al., 2006; Tompkins et al., 2009 ). Others such as BRCA1 (Foray et al., 2002; Ting and Lee, 2004) and ATM Kharbanda et al., 1997b) modulate the DNA signaling cascade by post-translational modifications such as ubiquitination and phosphorylation. Abl also interacts with DNA-PK (Kharbanda et al., 1997a; Durocher and Jackson, 2001; Gellert, 2002) . DNA-PK is an important component of the non-homologous end joining repair mechanisms of DSBs (Burma and Chen, 2004) . Experiments in Abl-null cells did not reveal any essential role of Abl in DNA repair per se Takao et al., 2000) . On the other hand, recent reports indicate that the formation of Rad51 foci is defective in Abl-null cells challenged by IR (Yuan et al., 2003) . Despite this wealth of observations, the role of Abl in DNA repair remains unclear. The picture is further complicated by the fact that 'constitutive' binding of the Abl SH3 domain to proteins containing PxxP motifs does not induce kinase activation per se. This raises an intriguing point: Does Abl engaged in such DNA repair protein complexes take on an autoinhibited conformation? In other words, is this fraction of nuclear Abl 'sensitive' to imatinib? In these complexes, are there other proteins involved in keeping the kinase in an inert state (Wang, 2004) ?
The large C-terminal segment of Abl has a domain directly involved in binding DNA (Shaul, 2000; Shaul and Ben-Yehoyada, 2005) . This domain binds deformed DNA structures such as four-way junctions (DavidCordonnier et al., 1998) as the high mobility group-1 domain. Interestingly, high mobility group-1 domain specifically recognizes the DNA intrastrand crosslinks formed by cisplatin (Chow et al., 1995; Ohndorf et al., 1999) . Such a finding suggests that Abl, similarly to high mobility group-1, may be recruited directly to cisplatinmodified DNA regions (Shaul, 2000) .
In short, Abl, through its modular domains, has the potential to act as a kinase/scaffold protein, thus favoring the formation of signaling complexes in the proximity of DNA structures that may be generated during replication/recombination or induced by genotoxic agents. In some circumstances the tyrosine kinase activity of Abl is dispensable and Abl recruitment turns out to be the only requirement to achieve a specific function. In response to UV irradiation, for instance, the Abl kinase activity is not activated, while the PTK domain of Abl is required for binding damage-specific DNA binding protein-1 (p127) (Cong et al., 2002) and necessary and sufficient for DNA binding protein-2 (p84) ubiquitination (Chen et al., 2006) .
Recent evidence suggests a model by which Abl functions as a hub 'sensing' the damage, the progress of repair and, if necessary, promotes degeneration of the follicle reserve, when the DNA damage proves irrepar-able (Gonfloni, 2010) . Interestingly, such a role is supported at the molecular level by the interaction of Abl with members of the p53 family.
Abl (nuclear function) meets the p53 family
According to a recent model, the MRN complex (comprising Mre11, Rad50 and NBS1) functions as an initial sensor of DNA breaks (Petrini and Stracker, 2003) , allowing the transient localization of many other DNA damage repair proteins (Celeste et al., 2003; Yuan and Chen, 2010) . At the same time, the MRN complex also facilitates activation of ATM/DNA-PK/ATR kinases (Carson et al., 2003; Uziel et al., 2003; Falck et al., 2005; Lee and Paull, 2005) , phosphorylation of H2AX (Rogakou et al., 1999) and initiation of DNA damage checkpoints (Lukas et al., 2003) . In short, DNA breaks firstly promote DNA repair and also a DNA signaling cascade for assisting repair or, if necessary, a pro-apoptotic path. Abl forms complexes with DNA repair machinery (Shaul, 2000) and also has a pro-apoptotic role following IR (Kharbanda et al., 1997b) . Protein accumulation and induction of proapoptotic genes as the response to DNA-damaging agents have been described for p53 (Junttila and Evan, 2009) . Abl activity inhibits the p53 ubiquitin ligase MDM-2 through phosphorylation, and in this way p53 becomes stabilized (Goldberg et al., 2002) . Abl also induces apoptosis in p53-null cells, suggesting that p53 is dispensable for Abl-dependent pathways leading to cell death. Indeed, Abl and its substrate p73 (a p53-related protein) have been implicated in an IR-induced pathway eliciting apoptosis (Agami et al., 1999; Gong et al., 1999) . Several reports provide evidence for a direct involvement of MMR system in promoting Abl activation following DNA damage (Nehme et al., 1997; Gong et al., 1999; Yi et al., 2006; Tompkins et al., 2009) . Accordingly, an Abl-dependent p73 accumulation is not seen in cells deficient in mismatch repair (Gong et al., 1999) upon cisplatin treatment. Lastly, Abl activation induces apoptosis through p73 and caspases (Wang and Ki, 2001 ). Interestingly, whereas p53 induction, following genotoxic stress, is not dependent on the cell cycle, p73 accumulation does occur when damaged cells are blocked in the S or G2 phases of the cell cycle (Wang and Ki, 2001 ).
Abl and germ cells
Germ cells have evolved unique mechanisms to deliver an intact genome to the offspring despite constant assaults by endogenous and environmental agents damaging DNA. In both the developing ovary and testis, germ cells undergo mitotic proliferation before birth, although the time of entry into meiosis and the duration of meiosis are strikingly different between the sexes (Figure 1 ). Formation of DSBs occurs normally during meiosis. DSBs in meiosis promote several major events beyond recombination and synaptonemal complex formation (Richardson et al., 2004) . Cells can take advantage of DSB-induced recombination in order to generate genetic diversity, given that homologous recombination is a central event in meiosis in almost all organisms. Abl expression was previously detected in male and female germ cells (Lev et al., 1984; Ponzetto and Wolgemuth, 1985; Meijer et al., 1987; Oppi et al., 1987; Iwaoki et al., 1993) . Although the mouse Abl gene is expressed in all tissues as two prominent mRNA species of 5.5 and 6.5 kb (Wang and Baltimore, 1983) , Abl expression appears to be maximal in testis, where both the 5.5 and 6.5-kb species are present, along with another species of 4.0 kb that is expressed at 5-to 10-fold higher levels (Muller et al., 1982; Ponzetto and Wolgemuth, 1985; Propst et al., 1988) . Sequence analysis of testis-specific cDNA clones indicated that the 4.0-kb transcript only differs in the 3' UTR (Oppi et al., 1987) . This is due to an alternative polyadenylation site of Abl transcripts that does not alter the coding capacity of the transcripts.
The Abl gene is highly conserved during evolution and Abl-related genes have been detected in the genomes of a large variety of organisms (Goff et al., 1980) , Drosophila melanogaster (Shilo and Weinberg, 1981) and Caenorhabditis elegans (Goddard et al., 1986) . The Dash (Drosophila homologs of Abl) transcript (6.2 kb), found in unfertilized eggs (as a maternal RNA), is extremely specific and restricted to a defined developmental stage (Lev et al., 1984) ; in fact, it was not detected in embryonal larval or adult RNA. Abl-1, the C. elegans homolog of mammalian ABL-1, is predicted to encode a full-length protein of 122 kDa, including a tyrosine kinase domain and the Src homology domains SH2 and SH3. Similarly to human Abl, C. elegans ABL-1 has a long C-terminal tail, a nuclear localization signal and a nuclear export signal. Deng et al. (2004) provided genetic evidence, in C. elegans, that Abl-1 deletion induces higher basal and radiation-induced germ-line apoptosis compared with wild-type worms. Interestingly, worms heterozygous with respect to Abl-1 do not have greater apoptosis than wild-type worms, indicating that lowering the Abl doses has no negative effect on the germ cells.
Early studies have shown that Abl interacts directly with meiotic chromosomes in mouse and rat testis. Meiotic crossing-over occurs at the pachytene stage when the Abl expression is the highest. Although a role for Abl activity in meiotic recombination is largely unclear, mice deficient in Abl exhibit defects in spermatogenesis (Tybulewicz et al., 1991; Hardin et al., 1996) . Taken together, these observations indicate that Abl seems to have a role in the maintenance of genomic integrity by dealing with DNA breaks in both meiotic and mitotic cells Pandita, 2003) .
In germ cells, mechanisms of genome surveillance may also rely on the most ancient member of the p53 family as an intermediary effector (Derry et al., 2001; Suh et al., 2006) . According to this model, the function of 'guardian' of the genome for p53 in the somatic cells derives from the function of 'guardian' of the germ line of its ancient cognate. Derry et al. (2001) identified a C. elegans gene encoding a protein, CEP-1, with signature sequences common to the p53 family. CEP-1 appears to be the only p53 family member encoded in the C. elegans genome; this suggests that p53 paralogs (including p63 and p73) may have evolved from a single ancestor related to CEP-1. The pro-apoptotic function of CEP-1 is restricted to the germ-line cells, and analysis of cep-1-KO animals also uncovered a meiotic role in the absence of genotoxic stress. This implies that cep-1 is required for chromosome segregation during meiosis (Derry et al., 2001) . Recent studies in mouse models have indicated that a p53 family member, TAp63-a, is expressed in the oocytes of the primordial follicles, albeit it is not involved in the development and maturation of oocytes (Kurita et al., 2005; Suh et al., 2006) . Conversely, TAp63-a is required in a process of DNA damage-induced oocyte death following IR (Suh et al., 2006) , but the mechanism responsible for oocyte degeneration is not yet clarified. Compelling evidence suggests that, following cisplatin exposure, Abl acts as a 'switch' for TAp63 activation and promotes oocyte death (Gonfloni et al., 2009 ). This reinforces the involvement of p63 in oocyte degeneration following DNA damage, thus matching the data derived from genetically tractable organisms such as flies and worms, each of which has a single p53-like gene (Brodsky et al., 2000 (Brodsky et al., , 2004 Ollmann et al., 2000; Derry et al., 2001; Schumacher et al., 2001 Schumacher et al., , 2005 Sogame et al., 2003) . Although these invertebrate genes are orthologs of the p53 gene, phylogenetic analyses indicate (Belyi et al., 2010; Rutkowski et al., 2010) that they are more related to the vertebrate p63 gene than to p53. In conclusion, our data support the observation that TAp63 is implicated in maintaining the genome integrity (Suh et al., 2006) according to an evolutionary conserved link between DNA damage and activation of a p53-related factor (Ko and Prives, 1996; Bourdon et al., 2005) . Furthermore, our findings outline a role of Abl in the mechanism leading to oocyte degeneration following chemotherapy.
In the cellular context of perinatal oocytes, the variety of cellular processes possibly affected by DNA-damage signaling pathways (Jackson and Bartek, 2009) has been narrowed down. The immature oocytes of the follicle reserve are arrested in meiosis I; thus, the efficiency of DNA repair is the only critical determinant of cell fate (Figure 2) .
During meiosis, a large number of effectors, enzymes and auxiliary proteins are involved in controlling the balance between genomic stability and diversity. Several studies have suggested a role for Abl in such processes. Several germ cells undergo apoptosis during this time, substantially reducing the pool of developing oocytes. Before birth all the surviving oocytes enter a period of extended meiotic arrest and are surrounded by somatic cells, forming primordial follicles. Later, individual primordial follicles are stimulated to initiate growth throughout the reproductive lifespan. This process continues until the cohort of oocytes is depleted and the woman enters menopause. Males: after birth the male germs or spermatogonia resume mitotic proliferation, with sexual maturity; spermatogonia continue to proliferate mitotically and send daughter cells into meiosis; sperm production is maintained throughout the lifetime of the male.
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Rad51, converting DSBs to recombinational intermediate, forms a complex with Abl (Yuan et al., 1998) . Abl was shown to inhibit binding of RAD51 to DNA in vitro by phosphorylating it on Tyr-54 (Yuan et al., 1998) or to promote the association of RAD51 with RAD52 through the phosphorylation of Tyr-315 of RAD51 (Shimizu et al., 2009) . In RAD51 these two tyrosine sites can be targeted by Abl and may have a negative and/or a positive role for repair by the homologous recombination repair mechanism. Also, Abl forms a complex with DNA-PK (Kharbanda et al., 1997b) . The latter has an essential role in V(D)J DNA recombination (Lieber et al., 2004) . Mammalian mismatch repair gene family members are also involved in meiotic recombination (reviewed by Stojic et al., 2004) and deficiency of mismatch repair protein functions (MutS homolog 5 and 4) in mice has revealed profound meiotic defects (Edelmann et al., 1999; Kneitz et al., 2000) . Recent evidence also reveals that Abl is directly associated with MSH5, a member of the mismatch repair family of proteins (Her and Doggett, 1998) . The interaction between MSH5 and Abl is mediated by the SH3 domain of Abl, and (PX) 5 dipeptide repeat flanked the two PxxP motifs (Yi et al., 2006) . Interestingly, disruption of the (PX) 5 dipeptide repeat in the hMSH5 P29S variant encoded by a common polymorphic allele hMSH5C85T has been potentially linked to the occurrence of ovarian cancer and premature ovarian failure (Yi et al., 2005; Mandon-Pepin et al., 2008) . Recently, Tompkins et al. (2009) have shown that interaction between hMSH5 and Abl confers IRinduced apoptotic response by promoting Abl activation and p73 accumulation. The effects are greatly enhanced in cells expressing hMSH5
P29S
, thus leading to increased IR sensitivity owing to enhanced caspase-3-mediated apoptosis. However, additional experiments are required to understand the effect of the hMSH5-Abl complex in DNA damage response and/or DNA repair, and the picture is complicated by the observation that h-RAD51 co-exists with hMSH5 and Abl in the same protein complex (Her et al., 2007) .
Working hypothesis
The conclusions from the experimental results compiled above outline a model that can immediately be tested by experimental strategies. In short, Abl seems to function as a key transducer by its ability to integrate signals and to convert such signals into a range of catalytic outcomes that can have positive (low activation) or negative (high activation) effects on DNA repair (Figure 3 ). This view is further supported by the fact that lowering Abl activity with imatinib increases the capacity of germ cells to repair lesions and so survive.
Previous data showed that overproduction of p73 together with Abl is sufficient to induce apoptosis in fibroblasts (Agami et al., 1999; Yuan et al., 1999) . Phosphorylation of Abl substrates like p73 and RAD51 is detectable in overexpression. This can be in part explained by the fact that in physiological conditions, Abl (activity) is repressed by keeping the concentration of nuclear Abl at a low level. Following DNA damage, Abl needs to be targeted by several post-translational modifications (Chen et al., 1999b; Yoshida et al., 2005; Raina et al., 2006; Jones et al., 2007) to allow accumulation and, finally, its activation in the nucleus. While in the germ cells, Abl transcripts are very abundant and the protein content is high (our unpublished observations); this is consistent with its functional role in meiosis and in the mismatch repair mechanism. TAp63 is also highly expressed in the nucleus of immature oocytes. In the proposed model, there is no need to reach a lethal threshold of protein concentration; in fact, even a sublethal (DNA) insult to somatic cells is sufficient to trigger degeneration of germ cells. This may neatly explain why the oocytes of the primordial follicles are extremely sensitive to DNA stressors. The high concentration and co-localization (Kuriyan and Eisenberg, 2007) of Abl and TAp63 in germ cells are enough in themselves to promptly trigger a (pro-apoptotic) signaling cascade. In immature oocytes, because of their tetraploid condition, we can reasonably hypothesize that there is no need for signaling amplification by transducers and effectors/ check-point controls. Mechanistically, TAp63 phosphorylation by Abl may offer a simple way for titrating Abl out from the mismatch repair complex on the DNA by competitive binding. The presence of three tyrosine A large number of enzymes and auxiliary proteins are devoted to repairing DNA lesions generated by endogenous and environmental agents damaging DNA. Sensors initiate signaling pathways that have an impact on a wide variety of cellular processes in somatic cells. Transducers and effectors are involved in signal amplification; this mainly impinges on checkpoint proteins and p53 causing cell-cycle arrest, senescence and apoptosis. Conversely, the DNA damage response in meiotic arrested oocytes is only restricted at two antagonistic roads: survival by DNA repair or a death fate.
DNA damage in germ cells: c-Abl takes center stage S Gonfloni residues carrying the specific consensus sequence for the SH2 domain of Abl seems to indicate a processive multisite phosphorylation of an elective substrate. All the tyrosines targeted in TAp63 match the sequence specificity of the Abl SH2 domain, having a proline residue in position þ 3 (Songyang et al., 1993) ; TAp63 also has a PxxP motif in its sequence for the Abl SH3 domain. This model, although speculative, has a real potential in linking the progressive activation of Abl, which depends on the extent of the lesions, and the release of Abl from the molecular machinery devoted to repairing the lesions. In addition, in this scenario, the effect of imatinib in protecting the germ cells consists in preventing the phosphorylation of TAp63 and thereby the consequent release of Abl from repair protein complexes.
What about possible accessory roles for Abl? One can argue that Abl possibly recruited in chromatin along with DNA repair proteins merely functions as a 'scaffold'. Conversely, a progressive activation of Abl may affect the assembly of DNA repair systems. In this context, Yuan describes a tyrosine site of RAD51, which, when phosphorylated by Abl, can exert a negative effect for DNA repair (Yuan et al., 1998) . A negative role for repair can also be exerted by Abl phosphorylation of DNA-PK, a key component of the non-homologous end joining system (Kharbanda et al., 1997a) . Such multifaceted functions of Abl or its catalytic outputs may provide the complex 'switchable' mechanism required for surveillance of genome integrity in the germ line. It might be that germ-line surveillance mechanisms are not linked to transcription of target pro-apoptotic genes at all.
Future challenges
Fertility preservation is an increasingly urgent issue for female cancer survivors (Backhus et al., 2007; Dunn and Fox, 2009; Hulvat and Jeruss, 2009; Johnston and Wallace, 2009; Maltaris et al., 2009; Peate et al., 2009; Jeruss and Woodruff, 2009; Woodruff, 2009; van der Kaaij et al., 2010; Gardino et al., 2010) . This is also due to rapid advances in reproductive technologies (Maltaris et al., 2008; West et al., 2009) . Nevertheless, the optimal time to address the issue of fertility for patients is before treatment, rather than during or after it. Thus, the options available for preserving fertility strongly depend on the age of patients and on the urgency of the treatment required (Woodruff, 2007 (Woodruff, , 2008 (Woodruff, , 2009 . Fertility preservation can be achieved firstly by trying to prevent infertility through co-medication. Adjuvant hormonal therapies have not provided the effective means of fertility preservation (Lobo, 2005) . A full knowledge of the molecular mechanisms used by damaged germ cells to repair lesions and survive would therefore provide clinical tools for preserving fertility during anti-cancer therapy. Co-treatment with imatinib has a protecting effect on the ovarian reserve. The challenge now is to clarify the mechanisms underlying such an effect. Further studies can only benefit from the successful development of other efficacious-clinically approved-inhibitors (ATP competitive and allosteric inhibitors) used against Abl kinases activated by genetic alterations in hematological malignancies (Adrian et al., 2006; Ohren and Sebolt-Leopold, 2006; Weisberg et al., 2007; Zhang et al., 2010) . Research is also needed to guarantee that the use of these agents will cause no birth defects. Whatever the case, the potential of imatinib and other Abl inhibitors as a therapeutic option for young women with cancer remains beyond doubt.
Concluding remarks
Although the mechanisms underlying the loss of oocytes induced by chemotherapy need to be further investigated, the efficiency of DNA repair is a critical determinant of germ-cell fate. Compelling evidence suggests a key role of Abl in dictating the fate of immature eggs challenged by genotoxic insults. Following cisplatin treatment, Abl phosphorylates TAp63 and promotes the death of germ cells, whereas pharmacological inhibition of Abl counteracts the effect of chemotherapy on the ovarian reserve. This implies that lowering Abl activation has an impact on the DNA repair. From preliminary results, oocytes, rescued by imatinib co-treatment, produce as many healthy offspring as untreated ones do. On the face of it, the endogenous repair mechanisms may reduce DNA breaks more efficiently. The question now is to establish the role of Abl and of its catalytic activation with regard to DNA repair: Does Abl mainly act as an 'assembler/ scaffold' by binding to several components involved in repairing the lesions? In my view, co-treatment with imatinib does not prevent DNA repair per se; it may, however, very likely impinge on the progressive activation of Abl required for a p63-dependent death fate.
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